Pharbaco CEO fined 524M VND, banned 18 months for unreported share purchase

Overview

The State Securities Commission of Vietnam (SSC) has fined Nguyễn Đình Tuấn, CEO and board member of Dược Phẩm Trung ương I – Pharbaco (PBC), nearly 524 million VND and suspended his securities trading for 18 months. The penalty stems from his failure to report a planned purchase of 3.49 million PBC shares, which he executed on April 28, 2026. The enforcement action adds to governance turmoil at the pharmaceutical firm, which has seen multiple senior executives resign.

Key Facts

• Nguyễn Đình Tuấn, CEO and board member of Pharbaco, was fined 523,731,000 VND (1.5% of the transaction value at par) for unreported share purchase.
• He bought 3,491,540 PBC shares on April 28, 2026, with a par value of 34,915,400,000 VND.
• The trading ban lasts 18 months, effective from the date of the decision (Decision No. 460/QĐ-XPHC).
• The purchase was executed via negotiated transactions totaling approximately 17.5 billion VND on April 28.
• Tuấn reported the transaction only on May 5, 2026, seven days after the purchase.
• Chairman Tô Thành Hưng, board members Lê Đức Hoàng and Nguyễn Thị Thu Hà, and Chief Accountant Nguyễn Đức Cảnh have all submitted resignations.
• The resignations are slated for approval at an extraordinary shareholder meeting; the record date for attendance is September 3, 2026.
• PBC shares closed at 5,300 VND on August 19, 2026, on the UPCOM exchange.

What Happened

According to the SSC’s administrative penalty decision, Nguyễn Đình Tuấn purchased 3,491,540 PBC shares on April 28, 2026, without filing a prior notice of intended trading, as required by securities regulations. He only reported the transaction on May 5, 2026. The fine was calculated at 1.5% of the transaction value based on par value, totaling nearly 524 million VND. In addition, his securities trading activities are suspended for 18 months.

The same day as the purchase, PBC recorded approximately 3.5 million shares traded via negotiated deals, with a total value of about 17.5 billion VND—matching the volume Tuấn later disclosed. The SSC’s decision was issued under Decision No. 460/QĐ-XPHC.

Separately, Pharbaco announced a series of resignations from senior executives. Chief Accountant Nguyễn Đức Cảnh resigned for personal reasons. Chairman Tô Thành Hưng, board members Lê Đức Hoàng and Nguyễn Thị Thu Hà also submitted resignations. These will be presented at an upcoming extraordinary shareholder meeting, though the meeting date has not been announced. The record date for shareholders to attend is set for September 3, 2026.

Market Context

PBC trades on the UPCOM exchange and closed at 5,300 VND on August 19, 2026. The stock has been under pressure amid governance instability. The fine and trading ban against the CEO, combined with the exodus of key executives, raise concerns about management continuity and compliance culture. The pharmaceutical sector in Vietnam remains attractive long-term, but PBC’s near-term outlook is clouded by these governance issues.

Strategic Significance

For long-term investors, this event highlights governance risk at Pharbaco. The failure to report a large share purchase by the CEO—and the subsequent resignations of the Chairman and other board members—signals potential internal discord and weak internal controls. The extraordinary shareholder meeting will be a key event to watch, as it may clarify the new leadership structure and strategic direction. Investors should assess whether the company can restore credibility and maintain operational stability amid these changes.

What to Watch

• Date and outcomes of the extraordinary shareholder meeting, including approval of resignations and appointment of new executives.
• Any further regulatory actions or fines against PBC or its executives.
• PBC’s quarterly earnings reports for signs of operational disruption.
• Changes in shareholding structure, especially any large block trades or acquisitions by new investors.
• Compliance improvements, such as new internal controls or governance policies announced by the company.